Search - Université de Rennes Access content directly

Filter your results

10 Results
Author: personID (integer) : 974361

Prospective cohort study of phenotypic variation based on an anal sphincter function in adults with fecal incontinence

C. Brochard , G. Bouguen , A. Bodère , A. Ropert , A.-L. Mallet et al.
Neurogastroenterology & Motility, 2016, 28 (10), pp.1554--1560. ⟨10.1111/nmo.12855⟩
Journal articles hal-01380420v1

A negative screening does not eliminate tuberculosis risk under anti-TNF treatment in inflammatory bowel disease: a descriptive study

Y. Abitbol , D. Laharie , J. Cosnes , M. Allez , S. Nancey et al.
Journal of Crohn's and Colitis, 2016, 10 (4), pp.S382--S382. ⟨10.1016/S0016-5085(16)31437-8⟩
Journal articles hal-01335062v1

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

A. Amiot , M. Serrero , L. Peyrin-Biroulet , J. Filippi , B. Pariente et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (3), pp.310-321. ⟨10.1111/apt.14167⟩
Journal articles hal-01639670v1

Recommandations de pratique pour le diagnostic et la prise en charge de la rectocolite hémorragique

A. Amiot , S. Viennot , M. Uzzan , P. Riviere , G.L. Cosquer et al.
Hépato-Gastro & Oncologie Digestive, 2022, 29 (3), pp.1-55. ⟨10.1684/hpg.2022.2336⟩
Journal articles hal-03718114v1

Switch from intravenous to subcutaneous infliximab in inflammatory bowel disease: Which consequences from a pharmacokinetic perspective?

B. Franck , M.C. Verdier , E. Bellissant , G. Bouguen , F. Lemaitre et al.
Fundamental & Clinical Pharmacology, 2022, 36, pp.43-43
Journal articles hal-03789365v1

Autoimmune pancreatitis associated with inflammatory bowel disease: a multicentric study of the GETAID

D. Lorenzo , F. Maire , C. Stefanescu , J. M. Gornet , P. Seksik et al.
Journal of Crohn's and Colitis, 2016, 10 (4), pp.S221--S222. ⟨10.1016/S0016-5085(16)30830-7⟩
Journal articles hal-01335059v1
Image document

Letter: wide variation in faecal calprotectin values according to the assay

S. Sun , T. Cavey , L. Peltier , C. Bendavid , G. Bouguen et al.
Alimentary Pharmacology and Therapeutics, 2016, 43 (1), pp.166-180. ⟨10.1111/apt.13455⟩
Journal articles hal-01243033v1
Image document

Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997

M.-L. Rabilloud , E. Bajeux , L Siproudhis , S. Hamonic , M. Pagenault et al.
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (9), pp.101974. ⟨10.1016/j.clinre.2022.101974⟩
Journal articles hal-03780614v1
Image document

Identification of the optimal medical and surgical management for patients with perianal fistulising Crohn’s disease

Mathilde Laland , Marie François , Ferdinando d'Amico , Camille Zallot , Charlène Brochard et al.
Colorectal Disease, 2023, 25 (1), pp.75-82. ⟨10.1111/codi.16314⟩
Journal articles hal-03777167v1

Natural history of perianal Crohn's disease: long-term follow-up on a population-based cohort

M. -L. Rabilloud , A. -L. Mallet , L. Siproudhis , Emma Bajeux , Jean François Viel et al.
Journal of Crohn's and Colitis, 2016, 10 (suppl 1), pp.S175--S176. ⟨10.1093/ecco-jcc/jjw019.290⟩
Journal articles hal-01359565v1